Malignant Gastric Neoplasm — Trials

Malignant Gastric Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,844 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 650
Recruiting: 353
Ph III recruiting: 49
Growth YoY: +15.1%
Industry share: 26%
Top sponsor: Fudan University
Termination share: 26.1%
Trials / 1,000 deaths: 59.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (232)

clinicaltrialsPublishedShowing 401–450 of 862 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07400354	The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota	recruiting	—	300	Fudan UniversityOTHER	1	Feb 10, 2026	clinicaltrials
NCT04368702	CONFIRM: Magnetic Resonance Guided Radiation Therapy(CONFIRM)	recruiting	N/A	70	Brigham and Women's HospitalOTHER	1	Feb 9, 2026	clinicaltrials